BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hajifathali A, Parkhideh S, Kazemi MH, Chegeni R, Roshandel E, Gholizadeh M. Immune checkpoints in hematologic malignancies: What made the immune cells and clinicians exhausted! J Cell Physiol 2020;235:9080-97. [DOI: 10.1002/jcp.29769] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Hu LF, Lan HR, Huang D, Li XM, Jin KT. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand? Front Oncol 2021;11:769305. [PMID: 34888246 DOI: 10.3389/fonc.2021.769305] [Reference Citation Analysis]
2 Kazemi MH, Momeni-varposhti Z, Roshandel E, Sankanian G, Hosseini Rouzbahani N, Ghorban K, Rajaeinejad M, Hajifathali A. Association of HLA alleles with hematologic malignancies. Gene Reports 2021;25:101346. [DOI: 10.1016/j.genrep.2021.101346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jin KT, Du WL, Liu YY, Lan HR, Si JX, Mou XZ. Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements. Cancers (Basel) 2021;13:588. [PMID: 33546172 DOI: 10.3390/cancers13040588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jin K, Mao C, Chen L, Wang L, Liu Y, Yuan J. Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma. Cancers (Basel) 2021;13:E229. [PMID: 33435205 DOI: 10.3390/cancers13020229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nalini R, Roshandel E, Tavakoli Ardakani M, Kazemi M, Gaffari-nazari H, Hajifathali A, Soleimani M. Soluble T Cell Immunoglobulin and Mucin Domain-3 (sTIM-3) Predict Graft-Versus-Host Disease (GVHD) in Iranian Allogeneic Hematopoietic Stem Cell Transplantation. Int J Cancer Manag 2022;15. [DOI: 10.5812/ijcm-120888] [Reference Citation Analysis]
6 Mehdizadeh M, Parkhideh S, Salari S, Roshandel E, Kazemi MH, Bonakchi H, Soleimani M, Hajifathali A. Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience. Med J Islam Repub Iran 2021;35:145. [PMID: 35321387 DOI: 10.47176/mjiri.35.145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Roshandel E, Tavakoli F, Parkhideh S, Akhlaghi SS, Ardakani MT, Soleimani M. Post-hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors. Health Sci Rep 2022;5:e536. [PMID: 35284650 DOI: 10.1002/hsr2.536] [Reference Citation Analysis]
8 Kazemi MH, Kuhestani Dehaghi B, Roshandel E, Parkhideh S, Mehdizadeh M, Salimi M, Hajifathali A, Hamidpour M. Oncolytic virotherapy in hematopoietic stem cell transplantation. Hum Immunol 2021;82:640-8. [PMID: 34119352 DOI: 10.1016/j.humimm.2021.05.007] [Reference Citation Analysis]
9 Kazemi MH, Najafi A, Karami J, Ghazizadeh F, Yousefi H, Falak R, Safari E. Immune and metabolic checkpoints blockade: Dual wielding against tumors. Int Immunopharmacol 2021;94:107461. [PMID: 33592403 DOI: 10.1016/j.intimp.2021.107461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Noorazar L, Bonakchi H, Sankanian G, Parkhideh S, Salimi M, Hajifathali A, Mirfakhraie R, Roshandel E. The effect of granulocyte colony-stimulating factor dose and administration interval after allogeneic hematopoietic cell transplantation on early engraftment of neutrophil and platelet. J Clin Lab Anal 2021;:e24060. [PMID: 34674310 DOI: 10.1002/jcla.24060] [Reference Citation Analysis]
11 Roshandel E, Noorazar L, Farhadihosseinabadi B, Mehdizadeh M, Kazemi MH, Parkhideh S. PI3 kinase signaling pathway in hematopoietic cancers: A glance in miRNA's role. J Clin Lab Anal 2021;35:e23725. [PMID: 33675064 DOI: 10.1002/jcla.23725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Carpenter AB, Carpenter AM, Aiken R, Hanft S. Oncolytic virus in gliomas: a review of human clinical investigations. Ann Oncol 2021;32:968-82. [PMID: 33771666 DOI: 10.1016/j.annonc.2021.03.197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Rauofi A, Hajifathali A, Karami S, Tavakoli F, Roshandel E, Bonakchi H, Parkhideh S. The apheresis content analysis in Allo-HSCT represents reliable influential factors on graft-versus-host disease and overall survival. Transfus Apher Sci 2021;60:103009. [PMID: 33608218 DOI: 10.1016/j.transci.2020.103009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]